|
| |
| | | 56072 | | 01.12.2003 | | Merck (Schweiz) AG | | 01.10.2007 | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Erbitux 2 mg/ml | Infusionslösung | Infusion solution () | L01FE01 | CI | | 02 | Erbitux 100 mg/20 ml | Infusionslösung | Infusion solution (Cetuximab 100mg / 20ml) | L01FE01 | CI | | 03 | Erbitux 500 mg/100 ml | Infusionslösung | Infusion solution (Cetuximab 500mg / 100ml) | L01FE01 | |
|
|
|
